PO.3.73 Soluble CD200 concentration in serum is increased in SLE patients and correlates with anti-dsdna

PO.3.73 Soluble CD200 concentration in serum is increased in SLE patients and correlates with anti-dsdna

Bibliographic Details
Main Authors:	M Limper, E Kaan, M Van Der Vlist
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-10-01
Series:	Lupus Science and Medicine

Similar Items

PO.3.53 No evidence of a correlation between serum HCQ concentrations and QTc in SLE
by: K Kultima, et al.
Published: (2022-10-01)

CD200 and CD200R Expression on Peripheral Blood Lymphocytes and Serum CD200 Concentration as a New Marker of Endometriosis
by: Monika Abramiuk, et al.
Published: (2020-09-01)

Anti-dsDNA B-Cell ELISpot as a Monitoring and Flare Prediction Tool in SLE Patients
by: Albert Pérez-Isidro, et al.
Published: (2023-02-01)

The Effects of Flexibility on dsDNA–dsDNA Interactions
by: Chuanying Chen, et al.
Published: (2022-05-01)

PO.5.110 Plasma levels of osteopontin in SLE
by: M Compagno, et al.
Published: (2022-10-01)

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
by: Silvana Morello, et al.
Published: (2017-12-01)

P73 Predictors of flares after glucocorticoid discontinuation in remitted patients with SLE
by: Andrea Doria, et al.
Published: (2024-03-01)

PO.8.176 Inflammation in blood and placenta in SLE pregnancies
by: M Saleh, et al.
Published: (2022-10-01)

<b>Apresentação</b> - doi: 10.4025/dialogos.v10i3.73 <b>Foreword</b> - doi: 10.4025/dialogos.v10i3.73 Presentación
by: Sidnei Munhoz
Published: (2010-05-01)

Identification of a novel conserved signaling motif in CD200 receptor required for its inhibitory function.
by: Laura M Timmerman, et al.
Published: (2021-01-01)

SAMUDERA 373 /
by: Mustaqim Azman, author, editor 633757, et al.
Published: (2019)

PO.3.62 Cardiopulmonary disease in SLE- increasing trend!
by: S Balasubramanian, et al.
Published: (2022-10-01)

Alterations in B cell development, CDR-H3 repertoire and dsDNA-binding antibody production among C57BL/6 ΔD−iD mice congenic for the lupus susceptibility loci sle1, sle2 or sle3
by: Mohamed Khass, et al.
Published: (2017-01-01)

Soluble CD73 in Critically Ill Septic Patients - Data from the Prospective FINNAKI Study.
by: Suvi T Vaara, et al.
Published: (2016-01-01)

Decreased CD73+ Double-Negative T Cells and Elevated Level of Soluble CD73 Correlated With and Predicted Poor Immune Reconstitution in HIV-Infected Patients After Antiretroviral Therapy
by: Xinyue Wang, et al.
Published: (2022-04-01)

CD200/CD200 receptor axis in psoriasis vulgaris.
by: Aisha A Ismail, et al.
Published: (2020-01-01)

PO.2.51 Hyperferritinaemia and systemic disease : SLE or still’s disease?
by: N Bouziani, et al.
Published: (2022-10-01)

PO.8.164 Melanoderma induced by long-term use of hydoxychloroquine in SLE
by: N Bouziani, et al.
Published: (2022-10-01)

O30 Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients
by: Anders Larsson, et al.
Published: (2024-03-01)

PO.5.118 Functional multiparametric mri to assess renal involvement in SLE
by: M Schneider, et al.
Published: (2022-10-01)

Absolute absorption cross-section measurements of CO2 in the ultraviolet from 200 to 206 nm at 295 and 373 K
by: Karaiskou, A, et al.
Published: (2004)

PO.4.94 High B-cell polygenic risk is associated with dsDNA antibodies and nephritis in systemic lupus erythematosus
by: S Reid, et al.
Published: (2022-10-01)

PO.8.183 Sle female patient presented with fatal cytophagic histiocytic panniculitis
by: M Shalaby, et al.
Published: (2022-10-01)

Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE
by: Amit Saxena, et al.
Published: (2023-08-01)

PO.2.34 Anti-DNase i antibodies: an emerging diagnostic marker of SLE
by: A Trofimenko, et al.
Published: (2022-10-01)

LP-016 Anti-histone and anti-nucleosome antibodies, rather than anti-dsDNA antibodies are associated with interferon-induced biomarkers in Sudanese and Swedish SLE patients
by: Anders Larsson, et al.
Published: (2023-07-01)

Characterization of the CD200 receptor family in mice and humans and their interactions with CD200
by: Wright, G, et al.
Published: (2003)

Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.
by: Wright, G, et al.
Published: (2003)

CD200:CD200R Interactions and Their Importance in Immunoregulation
by: Katarzyna Kotwica-Mojzych, et al.
Published: (2021-02-01)

PO.2.50 Utility in clinical practice of anti-dsdna autoantibodies vs antidna crithidia luciliae in the diagnosis of systemic lupus erythematosus
by: S Holgado, et al.
Published: (2022-10-01)

PO.1.20 Prognostic biomarkers of organ damage in patients with newly diagnosed SLE
by: D Leonard, et al.
Published: (2022-10-01)

Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer
by: Ioannis A. Vathiotis, et al.
Published: (2021-03-01)

The Clinical Significance of CD73 in Cancer
by: Niklas Bach, et al.
Published: (2023-07-01)

Intrachain Dynamics of Large dsDNA Confined to Slitlike Channels
by: Jones, Jeremy Joseph, et al.
Published: (2013)

CD200/CD200R Paired Potent Inhibitory Molecules Regulating Immune and Inflammatory Responses; Part II : CD 200/CD200R Potential Clinical Applications
by: Drahomíra Holmannová, et al.
Published: (2012-01-01)

CD200/CD200R Paired Potent Inhibitory Molecules Regulating Immune and Inflammatory Responses; part I: CD200/CD200R Structure, Activation, and Function
by: Drahomíra Holmannová, et al.
Published: (2012-01-01)

Urgent percutaneous coronary intervention leads to a decrease in serum concentrations of soluble CD40 ligand
by: Ratković Nenad, et al.
Published: (2010-01-01)

El epitafio de Ovidio (Trist. III 3.73-76): la complejidad de la deixis al servicio de la sofisticación poética
by: Susana González Marín
Published: (2019-06-01)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
by: Hao Zhang, et al.
Published: (2023-09-01)

PO.6.125 Mindfulness- based intervention as part of treatment for systemic lupus erythematosus (SLE) patients
by: PR Fortin, et al.
Published: (2022-10-01)